Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bloembergen, W. E.
Right arrow Articles by Wolfe, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bloembergen, W. E.
Right arrow Articles by Wolfe, R. A.

Journal of the American Society of Nephrology, Vol 6, 184-191, Copyright © 1995 by American Society of Nephrology

REGULAR ARTICLES

A comparison of cause of death between patients treated with hemodialysis and peritoneal dialysis

WE Bloembergen, FK Port, EA Mauger and RA Wolfe
Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, USA.

Mortality rates associated with peritoneal dialysis (PD) have been found to be higher than those associated with hemodialysis (HD) among prevalent U.S. patients over the age of 55 in the preceding study. Given the substantial technical differences between PD and HD, causes of death might also be expected to differ between these dialytic modalities. In order to help elucidate the relative contributions of these technical differences and to further the understanding of the excess mortality observed among PD-treated dialysis patients, this epidemiologic study compared cause of death in prevalent HD- and PD- treated patients in a large national sample, adjusting for demographic characteristics. Data for patients prevalent on January 1 of the years 1987, 1988, and 1989, each with 1 yr of follow-up, were obtained from the U.S. Renal Data System. Patients were censored at transplantation. Death rates per 100 patient years for seven cause-of-death categories were compared between HD and PD, adjusting for age, race, gender, cause of ESRD (diabetes versus nondiabetes), and < 1 yr or > 1 yr of prior ESRD, by use of the Poisson regression. There were 42,372 deaths occurring over 170,700 patient years at risk. There was a significantly increased mortality risk for PD compared with HD for all cause-of-death categories, except malignancy, for which there was a higher mortality risk for HD. The excess all-cause mortality observed in PD-treated patients can be accounted for, in decreasing order, by infection (35%), acute myocardial infarction (24%), other cardiac causes (16%), cerebrovascular disease (8%), withdrawal (8%), and malignancy (- 6%).(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
 CMAJHome page
S. V. Jassal MB BCh MD, L. Trpeski MPH MD, N. Zhu MD, S. Fenton MD, and B. Hemmelgarn PhD MD
Changes in survival among elderly patients initiating dialysis from 1990 to 1999
Can. Med. Assoc. J., October 23, 2007; 177(9): 1033 - 1038.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
J. M. Beecroft, J. Zaltzman, R. Prasad, G. Meliton, and P. J. Hanly
Impact of kidney transplantation on sleep apnoea in patients with end-stage renal disease
Nephrol. Dial. Transplant., October 1, 2007; 22(10): 3028 - 3033.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
W. Van Biesen, F. Verbeke, and R. Vanholder
Cardiovascular disease in haemodialysis and peritoneal dialysis: arguments pro peritoneal dialysis
Nephrol. Dial. Transplant., January 1, 2007; 22(1): 53 - 58.
[Full Text] [PDF]

Home page
 BMJHome page
A. George, J. I Tokars, E. J Clutterbuck, K. B Bamford, C. Pusey, and A. H Holmes
Reducing dialysis associated bacteraemia, and recommendations for surveillance in the United Kingdom: prospective study.
BMJ, June 17, 2006; 332(7555): 1435 - 1435.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. Malyszko, J. S. Malyszko, S. Brzosko, S. Wolczynski, and M. Mysliwiec
Adiponectin Is Related to CD146, a Novel Marker of Endothelial Cell Activation/Injury in Chronic Renal Failure and Peritoneally Dialyzed Patients
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4620 - 4627.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. G. Stack
Determinants of Modality Selection among Incident US Dialysis Patients: Results from a National Study
J. Am. Soc. Nephrol., May 1, 2002; 13(5): 1279 - 1287.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
W. Van Biesen, R. Vanholder, D. Debacquer, G. De Backer, and N. Lameire
Comparison of survival on CAPD and haemodialysis: statistical pitfalls
Nephrol. Dial. Transplant., March 1, 2000; 15(3): 307 - 311.
[Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
W. VAN BIESEN, R. C. VANHOLDER, N. VEYS, A. DHONDT, and N. H. LAMEIRE
An Evaluation of an Integrative Care Approach for End-Stage Renal Disease Patients
J. Am. Soc. Nephrol., January 1, 2000; 11(1): 116 - 125.
[Abstract] [Full Text]

Home page
 J. Am. Soc. Nephrol.Home page
P. S. PARFREY and R. N. FOLEY
The Clinical Epidemiology of Cardiac Disease in Chronic Renal Failure
J. Am. Soc. Nephrol., July 1, 1999; 10(7): 1606 - 1615.
[Full Text]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673